Latest Therapeutics Jobs

Director, Oncology Translational Medicine, Clinical Biomarkers

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

GSK London US$189,750 – US$316,250 pa

Hybrid

Principal Programmer Analyst

Lead programming activities for one or more clinical studies, developing, maintaining and validating complex analysis packages to CDISC and Good Programming Practice standards. Act as technical mentor to junior programmers and lead programming support for regulatory interactions with the EMA and FDA. Works in an agile, squad-based team bridging scientific requirements with technical solutions, with R proficiency preferred.

GSK London

Hybrid

Senior Medical Director, Oncology Clinical Development - Sarcoma

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interaction. Serves as a senior member of the Clinical Matrix Team, mentoring Medical Directors and engaging external experts, with a minimum two-day on-site office presence.

GSK Zug, Switzerland US$284,250 – US$473,750 pa

On-site

Head, Oncology Clinical Development - ADCs

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

GSK Stevenage US$242,250 – US$403,750 pa

Hybrid

Head, Oncology Clinical Development - ADCs

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory approval and initial launch. Acts as senior clinical representative at governance forums and leads cross-functional collaboration across research, precision medicine, medical affairs and commercial in a global matrix.

GSK Waltham, United States US$242,250 – US$403,750 pa

Hybrid

Head, Oncology Clinical Development - ADCs

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.

GSK Zug, Switzerland US$242,250 – US$403,750 pa

Hybrid

Head, Oncology Clinical Development - ADCs

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory filing and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams across research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

GSK London US$242,250 – US$403,750 pa

Hybrid

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and drives strategy, go/no-go decisions and lifecycle planning.

GSK Upper Providence US$340,500 – US$567,500 pa

Hybrid

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and drives strategy, go/no-go decisions and lifecycle planning.

GSK USA - Pennsylvania - Upper Providence US$340,500 – US$567,500 pa

Hybrid

Clinical Development Senior Medical Director - Cardiovascular

Leads clinical development medical activities for cardiovascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Provides medical monitoring and safety oversight, serves as clinical point of contact with regulators and investigators, and leads a cross-functional clinical matrix team within the Cardiovascular Medicine group. Requires a medical degree, board certification in cardiovascular medicine and at least five years of clinical research experience.

GSK USA - Pennsylvania - Upper Providence US$284,625 – US$474,375 pa

Hybrid

Clinical Development Medical Director - Cardiovascular

Provides clinical and scientific leadership across cardiovascular clinical development programs, designing CDPs, study protocols and regulatory documents while overseeing medical monitoring and participant safety. Leads a cross-functional Clinical Matrix Team, partners with biology, translational sciences, regulatory and commercial groups, and serves as clinical point of contact for regulators, investigators and key experts. Hybrid role with at least two on-site days per week.

GSK USA - Pennsylvania - Upper Providence US$222,750 – US$371,250 pa

Hybrid

Principal (Senior Director), Commercial Enterprise AI Product Mgmt. - Knowledge Foundation and Insights Acceleration

Senior individual contributor shaping GSK's Enterprise AI opportunity portfolio across market research, competitive intelligence and knowledge graphs, deciding where forward-deployed engineering pods focus. Involves hands-on prototyping with LLMs and agentic systems, building business cases, defining success metrics and running executive conversations to fund and scale AI products.

GSK Waltham, United States US$195,525 – US$325,875 pa

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines

Accountable lead for real-world evidence and health outcomes research across RSV vaccine assets, both marketed and pre-launch. Drives data generation plan design, study execution, translation and dissemination, and engages external experts, HTA agencies and payer bodies to support access and value-based pricing. Sits on the Vaccines RWE leadership team, managing a portfolio of studies and matrix stakeholders.

GSK London €151,500 – €252,500 pa

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines

Accountable lead for real-world evidence and health outcomes research across RSV vaccine assets, spanning in-market and pre-launch. Drives data generation plan design, study execution, translation and dissemination, and engages HTA agencies, NITAG bodies and payer stakeholders to support access and value-based pricing. Sits on the Vaccines RWE & Health Outcomes leadership team, managing a portfolio of studies and analytic staff.

GSK Wavre, Belgium €151,500 – €252,500 pa

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines

Leads the global real-world evidence and health outcomes research strategy for RSV vaccines, serving as the single accountable point for data generation plans across in-market and pre-launch assets. Oversees study design, execution, translation and dissemination while engaging HTA agencies, guideline groups and payer stakeholders to support access and value-based pricing. Combines line management of analytic staff with cross-functional leadership across clinical, commercial and market access teams.

GSK USA - Pennsylvania - Upper Providence €151,500 – €252,500 pa